Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215. Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226. Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446. Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471. Case and Commentary Sep 2021 What Do Clinicians and Organizations Owe Patients With Recalled Implanted Devices or Materials? Michele A. Manahan, MD, MBA Breast implant-associated anaplastic large cell lymphoma and breast implant illness have prompted recalls of implants. AMA J Ethics. 2021;23(9):E679-684. doi: 10.1001/amajethics.2021.679. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page Next › Last page Last »
Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215.
Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226.
Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446.
Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471.
Case and Commentary Sep 2021 What Do Clinicians and Organizations Owe Patients With Recalled Implanted Devices or Materials? Michele A. Manahan, MD, MBA Breast implant-associated anaplastic large cell lymphoma and breast implant illness have prompted recalls of implants. AMA J Ethics. 2021;23(9):E679-684. doi: 10.1001/amajethics.2021.679.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.